InsidersTradesSigma
Track the Zydus Lifesciences Limited share price and the full directors' dealings record of the company, a publicly traded company based in India. Shares trade on the IN market, under the supervision of SEBI (PIT + SAST). Operating in the Health Care sector, Zydus Lifesciences Limited has logged 79 public disclosures. Market capitalisation: €1,121.3bn. The latest transaction was reported on 14 November 2025 (Purchase). Among the most active insiders: DEVAL DHIRAJBHAI SHAH. All data is openly available.
79
Insider Decl.
n/a
Thresholds
€278,512
6 ops.
Buy Volume
€112m
69 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Zydus Lifesciences Limited Hold (neutral), based on 31 analysts. Average price target: ₹1,093.73.
10Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 8,768 of 29,064 companies
61.4
score / 100
Value45
Quality78
FCF yld-0.5%
Earn yld4.5%
EV/EBITDA14.8x
ROE18%
Gross mgn71%
Net mgn19%
Debt/EBITDA1.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 14 November 2025
Declarations79 total
1,000 shares@ ₹963.522100.0% of flowEquity SharesSEBI:e4c9983cad445dddcd36a51c902c60061dd60bfb
292 shares@ ₹1,006.640410.4% of flowEquity SharesSEBI:f084c5e1280a5f936e24a6a81bbe585ac7c99387
10,000 shares@ ₹1,006.67551.6% of flowEquity SharesSEBI:b3facb9aefbc9b7ac34b3ca33b4b8fe8326744a5
30,000 shares@ ₹1,010.61944.8% of flowEquity SharesSEBI:cfcaf3f423b2b28861434fae2f825a0e396ebe63
292 shares@ ₹1,005.2510.4% of flowEquity SharesSEBI:0d1f28d530aa236354476c964eeeeeb666957d3a
17,534 shares@ ₹1,015.34772.8% of flowEquity SharesSEBI:e2c1f18ea620ac19daed7747cac15ffa1b8597a9
565,466 shares@ ₹1,008.658590.7% of flowEquity SharesSEBI:5c22120f18b9f1c212a3253d90cb63012e1a4f03
1,000 shares@ ₹1,009.074100.0% of flowEquity SharesSEBI:6cc46fa0dbaa4d39a66c9758dbed6dcd103b5497
500 shares@ ₹985.5717.4% of flowEquity SharesSEBI:cd3a6bd8cb6007d3435a8f5ad033858462c6327c
150 shares@ ₹1,010.925.4% of flowEquity SharesSEBI:7efa676e2a258a2991aa7c30e295d438648660f7
500 shares@ ₹999.5017.7% of flowEquity SharesSEBI:0d176f9aa7404b01db0f581bd9a54b4c101916d7
942 shares@ ₹999.5033.3% of flowEquity SharesSEBI:715fc80b346f4b97dd6588a5093fd8bfba9618f3
150 shares@ ₹1,018.105.4% of flowEquity SharesSEBI:e61986bce1b5b0ff9a5cd87b88e1fe07e0dfa688
862 shares@ ₹965.9814100.0% of flowEquity SharesSEBI:b5ed393a19bf54c74e1b47ce5757430b2f3c3788
76 shares@ ₹1,005.0041.1% of flowEquity SharesSEBI:0c481d49f86abff7255b05e0ae9c3d2858fe2982
3,852,363 shares@ ₹1,005.0040.9% of flowEquity SharesSEBI:68c7f0e6cd587d8285012be3973f402f8742b7d7
151 shares@ ₹1,005.00100.0% of flowEquity SharesSEBI:770b4e99f8857d44d2d995f270a67bdb5869f6e0
799 shares@ ₹1,005.009.9% of flowEquity SharesSEBI:baae34f999f5abca19033d4ef26667d92e9c41c1
460 shares@ ₹1,005.00100.0% of flowEquity SharesSEBI:6b91ee03f9c62c9856f384bcfa1cddf4d95a5f47
10,145 shares@ ₹1,005.00100.0% of flowEquity SharesSEBI:1c2535ce27e3334a8ec2063cec3b319c9a3aefb2
1,926 shares@ ₹1,005.0017.9% of flowEquity SharesSEBI:5845b83c30547b92130db56e41b53f987e3fc3bb
1,626 shares@ ₹1,005.0057.3% of flowEquity SharesSEBI:75e0d3cf7589340b1d90a40b9661f70270a85947
76 shares@ ₹1,005.0041.1% of flowEquity SharesSEBI:78b3a98a419bbfb1d0828c7a578df300fc9be848
76 shares@ ₹1,005.00100.0% of flowEquity SharesSEBI:63be9561da61ed3ff18f80ac9dd6cc76551268ab
152 shares@ ₹1,005.00100.0% of flowEquity SharesSEBI:459281f52994ee250886b4e52db64f8583101313
25 of 79 declarations
关于 Zydus Lifesciences Limited
Zydus Lifesciences Limited 是一家印度制药公司，专注于仿制药和生物制药产品的研究、开发和制造。该公司在孟买证券交易所上市，股票代码为 XBOM。